
»ù±¾ÇéÐÎ
½ð¾²Î¬£¬£¬£¬ÄУ¬£¬£¬½Î÷·á³ÇÈË£¬£¬£¬Öй²µ³Ô±¡£ÏÖÈÎÒ¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺרÈÎÎ÷ϯ¡£
ÁªÏµ·½Ê½
µØµã£º£º¹ã¶«Ê¡½ÃÅÊÐÅî½Çø¶«³É´å22ºÅ Ò¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺ
Óʱࣺ£º529020
ÓÊÏ䣺£ºwyuchemjjw@126.com
ÊÂÇéÂÄÀú
2017Äê7ÔÂÖÁ½ñ£¬£¬£¬Ò¼ºÅÓéÀÖAPP£¬£¬£¬Ò©Ñ§ÓëʳÎ﹤³ÌѧԺ£¬£¬£¬Ë¶Ê¿Éúµ¼Ê¦
2018Äê10ÔÂÖÁ2020Äê10Ô£¬£¬£¬Ò¼ºÅÓéÀÖAPP£¬£¬£¬½ÃÅÊд󿵽¡¹ú¼ÊÁ¢ÒìÑо¿Ôº£¬£¬£¬²©Ê¿ºó
½ÌÓý¼°Ñ§Ï°ÂÄÀú
2013Äê9ÔÂ-2018Äê6Ô£¬£¬£¬ÖÐɽ´óѧ»¯Ñ§Ñ§Ôº£¬£¬£¬²©Ê¿
2010Äê9ÔÂ-2013Äê6Ô£¬£¬£¬ÖÐɽ´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬£¬£¬Ë¶Ê¿
2006Äê9ÔÂ-2010Äê 6Ô£¬£¬£¬³¤´ºÊ¦·¶´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬£¬£¬Ñ§Ê¿
Ö÷ÒªÑо¿Æ«Ïò
Ö÷Òª´Óʲ¡Ô΢ÉúÎï¡¢ÃâÒßѧ¡¢·Ö×ÓÉúÎïѧÓ뻯ѧµÄ½»Ö¯Ñ§¿ÆÑо¿£¬£¬£¬Ö÷ÒªÑо¿Æ«ÏòΪÒßÃç×ô¼ÁºÍÒ©ÎïÔØÌåÉúÎïÖÊÁϵÄÉè¼ÆºÍÖÆ±¸ÒÔ¼°×ÔÈ»²úƷȪԴ¿¹Ñ×Ö¢¡¢¿¹Ö×Áö¡¢¿¹¹ÇÖÊËÉÉ¢ºÍÃâÒß»îÐÔ·Ö×ÓµÄɸѡºÍ×÷ÓûúÖÆÑо¿¡£»£»£½Ó´ý¶Ô´ËÑо¿Æ«Ïò¸ÐÐËȤµÄ˶ʿÑо¿ÉúºÍ±¾¿ÆÉú¼ÓÈë¡£
¿ÆÑÐÏîÄ¿
[1] ×ÔÈ»²úƷȪԴµÄÃâÒßµ÷Àí»îÐÔÒßÃç×ô¼Á·Ö×ÓµÄɸѡ¼°×÷ÓûúÖÆÑо¿£¬£¬£¬Ò¼ºÅÓéÀÖAPP¸ßÌõÀíÒý½øÈË²ÅÆô¶¯¾·Ñ£¬£¬£¬2021.01-2026.01£¬£¬£¬100Íò£¬£¬£¬Ö÷³Ö
[2] ÒùÑòÞ½´ÎÜÕ I ÒßÃç×ô¼ÁµÄÃâÒßµ÷Àí×÷Óü°»úÖÆÑо¿£¨81901678£©£¬£¬£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¬£¬£¬2020.01-2022.12£¬£¬£¬21 Íò£¬£¬£¬Ö÷³Ö£¬£¬£¬½áÌâ
½ÒÏþѧÊõÂÛÎÄ
[1] Pei-Qi Huang#, Kai-Wen Kang#, Dan-Yu Huang, Chun-Lin Zhao, Hao Zheng, Yong-Xin Luo, Yan Wen, Ming-Feng Zou, Dong-Li Li, Ri-Hui Wu, Yun-Cai Tian, Yong Tian, Wen-Huan Zhang, Jing-Wei Jin*, Sheng Yin*, Li-She Gan*. Lignan glucosides from Gentiana macrophylla with potential anti-arthritis and hepatoprotective activities. Phytochemistry, 2024, 217: 113920
[2] Ou Yi#, You Zonglin#, Yao Min, Cao Yingfan, Xue Xiu, Chen Min, Wu Rihui, Gan Lishe, Li Dongli, Wu Panpan, Xu Xuetao, Wong Wingleung, Wong Vincent Kam Wai, Liu Wenfeng*, Ye Jiming*, Jin Jingwei*. Naproxen-derived new compound inhibits the NF-¦ÊB, MAPK and PI3K/Akt signaling pathways synergistically with resveratrol in RAW264.7 Cells. Molecules, 2023, 28(8): 3395
[3] Yang Li#, Yajiao Jian#, Fan Xu, Yongxin Luo, Zhixuan Li, Yi Ou, Yan Wen, Jingwei Jin*, Chuanrui Zhang*, Lishe Gan*. Five new terpenoids from Viburnum odoratissimum var. sessiliflorum. Chinese Journal of Natural Medicines, 2023, 21(4): 298-307
[4] Tu Borong#, Liang Jinfeng#, Ou Yi, Zhang Xinyue, Zheng Wende, Wu Rihui, Gan Lishe, Li Dongli, Lu Yujing, Wu Jiaqiang, Hong WeiqianDavid , Zhang Kun, Wu Panpan*, Jin Jingwei*, Wong Wing-Leung*. Novel 18¦Â-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activity. Bioorganic Chemistry, 2022, 122: 105714
[5] Jin Jingwei#, He Hao#, Zhang Xinyue, Wu Rihui, Gan Lishe, Li Dongli, Lu Yujing, Wu Panpan*, Wong Wing-Leung*, Zhang Kun*. The in vitro and in vivo study of oleanolic acid indole derivatives as novel anti-inflammatory agents: Synthesis, biological evaluation, and mechanistic analysis, Bioorganic Chemistry, 2021, 113: 104981
[6] Jin Jingwei, Rong Minzhi*, Zhang Mingqiu*, Wong Wing-Leung*. Preparation of a water soluble aminated ¦Â-1,3-D-glucan for gene carrier: The in vitro study of the anti-inflammatory activity and transfection efficiency, Journal of Biomedical Materials Research Part A, 2021, 109(12): 2506-2515
[7] Jin Jingwei#, Hou Jinqiang#, Long Wei, Zhang Xinyue, Lu Yu-Ling, Li Dongli, Zhang Kun, Wong Wing-Leung*. Synthesis of fluorescent G-quadruplex DNA binding ligands for the comparison of terminal group effects in molecular interaction: phenol versus methoxybenzene, Bioorganic Chemistry, 2020, 99:103821
[8] Jin Jingwei#, Wu Panpan#, Zhang Xinyue, Li Dongli, Wong Wing-Leung*, Lu Yu-Ling*, Sun Ning*; Zhang Kun. Understanding the interaction of estrogenic ligands with estrogen receptors: a survey of the functional and binding kinetic studies, Journal of Environmental Science and Health, Part C, 2020, 38(2): 142-168
[9] Jin Jingwei, Tang Shunqing, Rong Minzhi*, Zhang Mingqiu*. Synergistic effect of dual targeting vaccine adjuvant with aminated ¦Â-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses. Acta Biomaterialia, 2018, 78: 211-223
[10] Jin Jingwei, Peng Weili, Tang Shunqing, Rong Minzhi*, Ming Zhangqiu*. Antigen uptake and immunoadjuvant activity of pathogen-mimetic hollow silica particles conjugated with ¦Â-glucan. Journal of Materials Chemistry B, 2018, 6: 6288-6301
[11] ½ð¾²Î¬£¬£¬£¬Âí±£»£»£»ª£¬£¬£¬ÇñË÷ƽ£¬£¬£¬Áè±ò±ù£¬£¬£¬ÀîºØ£¬£¬£¬ºúÏþ±ù£¬£¬£¬²ÜÓÀ³¤£¬£¬£¬Ñ¦´ºÒË. ¿ÚÌãÒß²¡¶¾½âÐýøºãÎÂÀ©Ôö¼ì²âÒªÁìµÄ½¨Éè. ¹óÖÝÐóÄÁÊÞÒ½£¬£¬£¬2014, 38 (5):1-5
[12] ½ð¾²Î¬£¬£¬£¬Áõ¼ÒÈ«£¬£¬£¬ÎâÈÕ»Ô£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÀÀû£¬£¬£¬ÁõÀÚ. ÆÑ¿û×Ó¶àÌǵÄÌáÈ¡¡¢ÊèÉ¢ºÍ±íÕ÷¡ª¡ª¡°Ê³ÎïÆÊÎöʵÑ顱¿Î³ÌÁ¢ÒìʵÑéÉè¼Æ. ¹ã¶«»¯¹¤£¬£¬£¬2023£¬£¬£¬50£¨18£©£º£º225-228
¼ÓÈëѧÊõ¾Û»á¼°ÂÛÎÄ
½ð¾²Î¬£¬£¬£¬ÈÝÃôÖÇ£¬£¬£¬ÕÂÃ÷Ç£¬£¬ÌÀ˳Çå. ÉúÎïÖÊÁÏÓÃË®ÈÜÐÔ°·»¯½ÍĸÆÏ¾ÛÌǵÄÖÆ±¸. 2015 ÄêÌìϸ߷Ö×ÓѧÊõÂÛÎı¨¸æ»á£¬£¬£¬BP-004£¬£¬£¬2015Äê10ÔÂ17ÈÕ-21ÈÕ£¬£¬£¬ËÕÖÝ
ÉêÇë¼°ÊÚȨרÀû
[1] ½ð¾²Î¬£¬£¬£¬ÁõÇ£¬£¬Áõ¼ÒÈ«£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÀÀû£¬£¬£¬ÎâÈÕ»Ô. Ò»ÖÖÅ£´óÁ¦¶àÌǵÄÖÆ±¸ÒªÁì¼°ÆäÔÚ¿¹¹ÇÖÊËÉÉ¢Ò©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202311545157.8, ÉêÇëÈÕÆÚ£º£º2023Äê11ÔÂ20ÈÕ
[2] ½ð¾²Î¬£¬£¬£¬Â¬Ñåö£¬£¬£¬ÁõÇ£¬£¬Áõ¼ÒÈ«£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÀÀû£¬£¬£¬ÎâÈÕ»Ô. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸¿¹¹ÇÖÊËÉÉ¢Ö¢ÖÆÆ·ÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202311555583.X, ÉêÇëÈÕÆÚ£º£º2023Äê11ÔÂ21ÈÕ
[3] ½ð¾²Î¬£¬£¬£¬Ò¦Ãô£¬£¬£¬Áõ¼ÒÈ«£¬£¬£¬ÀÀû£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÎâÈÕ»Ô£¬£¬£¬Â¬Ñåö£¬£¬£¬»ÆÓÀ˜Å. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸Ô¤·ÀºÍ/»òÖÎÁÆÂýÐԽ᳦Ñ×Ò©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202311241662.3, ÉêÇëÈÕÆÚ£º£º2023Äê9ÔÂ25ÈÕ
[4] ½ð¾²Î¬£¬£¬£¬Ò¦Ãô£¬£¬£¬Îâ¾´Ó꣬£¬£¬Áõ¼ÒÈ«£¬£¬£¬ÀÀû£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÎâÈÕ»Ô£¬£¬£¬»ÆÓÀ˜Å. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸Ìá¸ß»úÌåÃâÒßÁ¦ÖÆÆ·ÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202311247804.7, ÉêÇëÈÕÆÚ£º£º2023Äê9ÔÂ25ÈÕ
[5] ½ð¾²Î¬£¬£¬£¬Â¬Ñåö£¬£¬£¬ÀÀû£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÎâÈÕ»Ô£¬£¬£¬Ò¶¼½Ã÷£¬£¬£¬ÕÔÐü. Ò»ÖÖÌáÈ¡×éÖ¯»òϸ°ûÖиÊÓÍÈýõ¥µÄÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202310628534.8, ÉêÇëÈÕÆÚ£º£º2023Äê5ÔÂ30ÈÕ
[6] ½ð¾²Î¬£¬£¬£¬ÁõÇ£¬£¬Å·Ò壬£¬£¬ÓÎ×ÚÁØ£¬£¬£¬Ò¦Ãô£¬£¬£¬³ÂÀ¼Ç࣬£¬£¬ÁõÎķ棬£¬£¬ÎâÈÕ»Ô£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÀÀû. ÀÒ°±ËáøÒÖÖÆ¼Á¼°ÆäÔÚÖÆ±¸ÖÎÁÆÐþÉ«ËØÁöÒ©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202211330973.2, ÉêÇëÈÕÆÚ£º£º2022Äê10ÔÂ27ÈÕ. ÒÑÊÚȨ
[7] ½ð¾²Î¬£¬£¬£¬Å·Ò壬£¬£¬ÓÎ×ÚÁØ£¬£¬£¬Ò¦Ãô£¬£¬£¬ÁõÇ£¬£¬ÁõÎķ棬£¬£¬ÎâÈÕ»Ô£¬£¬£¬¸ÊÀñÉ磬£¬£¬ÀÀû. ÝÁÆÕÉú-Èâ¹ðËáÑÜÉúÎï¼°ÆäÔÚÖÆ±¸ÖÎÁÆLPSÓÕµ¼Ñ×Ö¢Ò©ÎïÖеÄÓ¦ÓÃ.Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202210895672.8, ÉêÇëÈÕÆÚ£º£º2022Äê7ÔÂ27ÈÕ
[8] ½ð¾²Î¬£¬£¬£¬ÕÅܰÔ£¬£¬£¬»ÆÓÀ˜Å£¬£¬£¬ÀÀû£¬£¬£¬ÕÅŸj. Ò»ÖÖ RAW 264.7 ϸ°ûÑ×֢ģ×ӵĽ¨ÉèÒªÁì.Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º202010784949.0, ÉêÇëÈÕÆÚ£º£º2020Äê8 ÔÂ6ÈÕ
[9] ½ð¾²Î¬£¬£¬£¬ÁÖ¶°È¨£¬£¬£¬»ÆÓÀ˜Å£¬£¬£¬ÀÀû£¬£¬£¬ÕÅŸj. ´úÉÃÌпµÄ¿ìËÙ¼ì²âÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º201910631936.7£¬£¬£¬ÉêÇëÈÕÆÚ£º£º2019Äê7ÔÂ12ÈÕ
[10] ½ð¾²Î¬£¬£¬£¬ÁÖ¼Ò»Ô£¬£¬£¬»ÆÓÀ˜Å£¬£¬£¬ÀÀû£¬£¬£¬ÕÅŸj. ¸£ÃÀË«µÄ¿ìËÙ¼ì²âÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º201910631200.X£¬£¬£¬ÉêÇëÈÕÆÚ£º£º2019Äê7ÔÂ12ÈÕ
[11] ÈÝÃôÖÇ£¬£¬£¬½ð¾²Î¬£¬£¬£¬ÕÂÃ÷Çï. Ò»ÖÖ¸ºÔØ¿¹ÔµÄË®ÈÜÐÔ°·»¯¦Â-1,3-D-ÆÏ¾ÛÌÇÄÉÃ×Á£×Ó¼°ÆäÖÆ±¸ÒªÁìºÍÓ¦ÓÃ, 2020-07-14, Öйú, ZL201810145959.2. ÒÑÊÚȨ
[12] ÈÝÃôÖÇ£¬£¬£¬½ð¾²Î¬£¬£¬£¬ÕÂÃ÷Çï. Ò»ÖÖ¦Â-1,3-D-ÆÏ¾ÛÌÇÐÞÊεķÂÉúÖпնþÑõ»¯¹è¸´ºÏÁ£×Ó¼°ÆäÓ¦ÓÃ, 2020-10-23, Öйú, ZL201810445055.1. ÒÑÊÚȨ
»ñ½±¼°ÉùÓþ
±¾¿ÆÊ±´ú£º£º»ñµÃÁ½´Î¹ú¼ÒÀøÖ¾½±Ñ§½ð¡¢Á½´ÎѧԺһµÈ½±Ñ§½ð¡¢Ò»´ÎѧԺ¶þµÈ½±Ñ§½ð¡¢´óѧÉúËØÖÊÑø³É¹¤³ÌA¼¶ÉùÓþÖ¤ÊéºÍÓÅÒì½áÒµÉú³Æºô
Ñо¿Éúʱ´ú£º£º»ñµÃгÏѧÉúÓÅÒìÂÛÎĽ±Ñ§½ð